Market Place
Sourcing Support
Amneal`s Generic Olmesartan Medoxomil Receives Approval in the U.S.
11 Jul 2023 //
FDA
MSN`s Generic Olmesartan Medoxomil Receives Approval in the U.S.
18 Jan 2023 //
FDA
Prinston`s Generic Olmesartan Medoxomil Receives Approval in the U.S.
02 Dec 2022 //
FDA
IOL Chemicals secures patent for invention related to preparation of Sartan drugs
27 Nov 2022 //
BUSINESS-STANDARD
Macleods Pharmaceuticals recalls products in US for manufacturing issues
28 Mar 2022 //
BUSINESS-STANDARD
Daiichi Sankyo’s triple combo drug shows promising real-world clinical data
24 Nov 2021 //
KOREABIOMED
Novartis Pharma`s ENTRESTO, now to treat hypertension in Japan
27 Sep 2021 //
PRESS RELEASE
Enforcement Report - Week of June 2, 2021
02 Jun 2021 //
FDA
Shortage of olmesartan and prazosin tablets
04 Sep 2020 //
TGA
Enforcement Report - Week of February 12, 2020
12 Feb 2020 //
FDA
Umedica Lab`s Generic Olmesartan Medoxomil Receives Approval In US
20 Jul 2019 //
FDA
FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India
18 May 2019 //
RAPS
NPPA fixes retail prices of 22 formulations under DPCO, 2013
06 May 2019 //
PHARMABIZ
TGA investigation - potential contamination with N-nitroso compounds
26 Feb 2019 //
TGA
Sunshine Lake`s Generic Olmesartan Medoxomil Receives Approval in US
25 Feb 2019 //
FDA
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
04 Feb 2019 //
EDQM
Enforcement Report - Week of January 23, 2019
23 Jan 2019 //
FDA
43 popular heart drugs found to contain carcinogens in Taiwan
19 Jan 2019 //
TAIWAN NEWS
FDA presents interim limits of nitrosamines in currently marketed ARBs
21 Dec 2018 //
FDA
Enforcement Report - Week of December 12, 2018
12 Dec 2018 //
FDA
Enforcement Report - Week of December 5, 2018
05 Dec 2018 //
FDA
EU authorities take further action in ongoing review of sartans
15 Oct 2018 //
EMA
Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with GMP
03 Oct 2018 //
HEALTH CANADA
EU, US Ban Manufacturer use of Valsartan From China’s Zhejiang Huahai
29 Sep 2018 //
RAPS
EMA review of impurities in sartan medicines
22 Sep 2018 //
PRESS RELEASE
EMA Extends Valsartan Review to Include Four More Active Substances
22 Sep 2018 //
RAPS
Valsartan: review of impurities extended to other sartan medicines
22 Sep 2018 //
EMA
List of New Paragraph IV Certifications as of Aug 21, 2018
21 Aug 2018 //
FDA
Prescription med: registration of new generics & biosimilars
05 Jun 2018 //
TGA GOV
Daiichi Sankyo to modify terms for US olmesartan products liability litigation
30 Mar 2018 //
PHARMABIZ
Daiichi Sankyo takes another big whack at U.S. sales operations
06 Mar 2018 //
FIERCE PHARMA
Zydus receives US FDA marketing nod for amlodipine & olmesartan medoxomil tablet
25 Sep 2017 //
PHARMABIZ
Daiichi Sankyo offers $300 million to settle 2,300 Benicar lawsuits
02 Aug 2017 //
FIERCE PHARMA
Jubilant gets USFDA nod for generic hypertension drug
23 May 2017 //
ECONOMIC TIMES
Lupin gets USFDA nod to sell generic hypertension drug in US
29 Apr 2017 //
BUSINESS-STANDARD
Alkem Labs Generic Olmesartan Medoxomil Receives Approval In US
26 Apr 2017 //
FDA
Jubilant Generics Olmesartan Medoxomil Receives Approval In US
26 Apr 2017 //
FDA
Zydus Pharms USA Generic Olmesartan Medoxomil Receives Approval In US
26 Apr 2017 //
FDA
Macleods Pharma’s Generic Olmesartan Medoxomil Receives Approval In US
26 Apr 2017 //
FDA
Aurobindo Pharma’s Generic Olmesartan Medoxomil Receives Approval In US
26 Apr 2017 //
FDA
Alembic Pharma gets USFDA nod for anti-hypertension drugs
26 Apr 2017 //
ECONOMIC TIMES
Jubilant Life gets USFDA nod for hypertension drug
25 Apr 2017 //
ECONOMIC TIMES
Torrent Pharms Generic Olmesartan Medoxomil Receives Approval In US
24 Apr 2017 //
FDA
Glenmark Pharms Ltd`s Generic Olmesartan Medoxomil Receives Approval In US
13 Jan 2017 //
FDA
